Pure Global
NCT06276894

Functional Near-Infrared Spectroscopy (fNIRS) Assessing Neural Activity During Virtual Reality Walking Intervention

Using Functional Near-Infrared Spectroscopy (fNIRS) to Assess Neural Activity During a Virtual Reality Walking Intervention: A Feasibility Study
Craig Hospital·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Traumatic Brain Injury
Drug/Device/Intervention
Motek C-Mill™ treadmill
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Craig Hospital
Location
Englewood, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Feb 01, 2025
Enrollment
15 participants
Primary outcome

Incidence of Treatment-Related Adverse Events (e.g., Safety and Tolerability),Acceptability of the intervention,fNIRS Data Quality

Summary

The purpose of this study is to evaluate the safety and feasibility of using a portable
 neuroimaging device called functional near-infrared spectroscopy (fNIRS) to successfully
 analyze fNIRS data in individuals with chronic TBI during treadmill training augmented with
 VR.

ICD-10 classifications
Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06276894
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06276894 through Pure Global AI's free database. This phase not specified trial is sponsored by Craig Hospital and is currently Not yet recruiting. The study focuses on Traumatic Brain Injury. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.